ATAD5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.97175609173428E-13 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
4.039202305961E-11 |
Normal-vs-Stage2 |
1.96532999999777E-05 |
Normal-vs-Stage3 |
7.78870301587631E-11 |
Normal-vs-Stage4 |
4.14559997441444E-09 |
Stage1-vs-Stage2 |
9.595800E-01 |
Stage1-vs-Stage3 |
4.650800E-01 |
Stage1-vs-Stage4 |
1.258770E-01 |
Stage2-vs-Stage3 |
5.802600E-01 |
Stage2-vs-Stage4 |
2.398600E-01 |
Stage3-vs-Stage4 |
3.545000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.57016630200724E-13 |
Normal-vs-AfricanAmerican |
1.59175999999706E-05 |
Normal-vs-Asian |
1.017740E-02 |
Caucasian-vs-AfricanAmerican |
3.175400E-01 |
Caucasian-vs-Asian |
3.996200E-02 |
AfricanAmerican-vs-Asian |
1.193630E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
4.54281057216122E-12 |
Normal-vs-Female |
4.5404791038095E-12 |
Male-vs-Female |
4.084000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.002800E-04 |
Normal-vs-Age(41-60Yrs) |
2.29871677248639E-12 |
Normal-vs-Age(61-80Yrs) |
4.63600269284825E-11 |
Normal-vs-Age(81-100Yrs) |
1.369980E-04 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.524800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.854600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.694800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.997800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.945600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.760400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.75998999999427E-05 |
Normal-vs-Grade 2 |
5.77760062014931E-12 |
Normal-vs-Grade 3 |
4.21250034854381E-10 |
Normal-vs-Grade 4 |
1.24050000049891E-07 |
Grade 1-vs-Grade 2 |
6.232000E-01 |
Grade 1-vs-Grade 3 |
3.374200E-01 |
Grade 1-vs-Grade 4 |
8.687400E-01 |
Grade 2-vs-Grade 3 |
3.831000E-01 |
Grade 2-vs-Grade 4 |
4.776600E-01 |
Grade 3-vs-Grade 4 |
2.298800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
3.73767683470305E-12 |
Normal-vs-ccB subtype |
1.48359990959079E-10 |
ccA subtype-vs-ccB subtype |
6.369000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.85063075974767E-12 |
Normal-vs-N1 |
1.976400E-03 |
N0-vs-N1 |
2.648000E-01 |
|
|